Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,549
Recruiting: 1,935
Ph III recruiting: 225
Growth YoY: +16.5%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 401–450 of 749 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06638931	Agnostic Therapy in Rare Solid Tumors(ANTARES)	recruiting	Phase 2	28	Instituto do Cancer do Estado de São PauloOTHER	1	Apr 15, 2026	clinicaltrials
NCT06799637	Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments	recruiting	Phase 1 / Phase 2	350	Evopoint Biosciences Inc.INDUSTRY	1	Apr 15, 2026	clinicaltrials